Cardiac troponin measurement at the point of care: educational recommendations on analytical and clinical aspects by the IFCC Committee on Clinical Applications of Cardiac Bio-Markers (IFCC C-CB)

Clin Chem Lab Med. 2023 Jan 16;61(6):989-998. doi: 10.1515/cclm-2022-1270. Print 2023 May 25.

Abstract

The International Federation of Clinical Chemistry and Laboarator Medicine (IFCC) Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) has provided evidence-based educational resources to aid and improve the understanding of important analytical and clinical aspects of cardiac biomarkers. The present IFCC C-CB educational report focuses on recommendations for appropriate use, analytical performance, and gaps in clinical studies related to the use of cardiac troponin (cTn) by point of care (POC) measurement, often referred to as a point of care testing (POCT). The use of high-sensitivity (hs)-cTn POC devices in accelerated diagnostic protocols used in emergency departments or outpatient clinics investigating acute coronary syndrome has the potential for improved efficacy, reduction of length of stay and reduced costs in the health care system. POCT workflow integration includes location of the instrument, assignment of collection and testing responsibility to (non-lab) staff, instrument maintenance, in-service and recurrent training, quality control, proficiency assessments, discrepant result trapping, and troubleshooting and inventory management.

Keywords: cardiac troponin I; cardiac troponin T; educational recommendations; point of care testing.

MeSH terms

  • Acute Coronary Syndrome* / diagnosis
  • Biomarkers
  • Chemistry, Clinical
  • Humans
  • Point-of-Care Systems*
  • Troponin
  • Troponin T

Substances

  • Biomarkers
  • Troponin
  • Troponin T